Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016;22(5):527-34.
doi: 10.2174/1381612822666151124235028.

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

Gohar Mushtaq  1 , Nigel H Greig  2 , Firoz Anwar, Fahad A Al-Abbasi, Mazin A Zamzami, Hasan A Al-Talhi, Mohammad A Kamal
Affiliations
Review

Neuroprotective Mechanisms Mediated by CDK5 Inhibition

Gohar Mushtaq et al. Curr Pharm Des. 2016.

Abstract

Cyclin-dependent kinase 5 (CDK5) is a proline-directed serine/threonine kinase belonging to the family of cyclin-dependent kinases. In addition to maintaining the neuronal architecture, CDK5 plays an important role in the regulation of synaptic plasticity, neurotransmitter release, neuron migration and neurite outgrowth. Although various reports have shown links between neurodegeneration and deregulation of cyclin-dependent kinases, the specific role of CDK5 inhibition in causing neuroprotection in cases of neuronal insult or in neurodegenerative diseases is not wellunderstood. This article discusses current evidence for the involvement of CDK5 deregulation in neurodegenerative disorders and neurodegeneration associated with stroke through various mechanisms. These include upregulation of cyclin D1 and overactivation of CDK5 mediated neuronal cell death pathways, aberrant hyperphosphorylation of human tau proteins and/or neurofilament proteins, formation of neurofibrillary lesions, excitotoxicity, cytoskeletal disruption, motor neuron death (due to abnormally high levels of CDK5/p25) and colchicine- induced apoptosis in cerebellar granule neurons. A better understanding of the role of CDK5 inhibition in neuroprotective mechanisms will help scientists and researchers to develop selective, safe and efficacious pharmacological inhibitors of CDK5 for therapeutic use against human neurodegenerative disorders, such as Alzheimer's disease, amyotrophic lateral sclerosis and neuronal loss associated with stroke.

PubMed Disclaimer

Conflict of interest statement

The authors confirm that this article content has no conflict of interest.

Figures

Fig. (1)
Fig. (1)
Structures of selected CDK5 inhibitors.
See this image and copyright information in PMC

References

    1. Dhavan R, Tsai LH. A decade of CDK5. Nat Rev Mol Cell Biol. 2001;2:749–759. - PubMed
    1. Gupta A, Tsai LH, Wynshaw-Boris A. Life is a journey: a genetic look at neocortical development. Nat Rev Genet. 2002;3:342–355. - PubMed
    1. Meyerson M, Enders GH, Wu CL, et al. A family of human cdc2-related protein kinases. EMBO J. 1992;11:2909–2917. - PMC - PubMed
    1. Malumbres M. Cyclin-dependent kinases. Genome Biol. 2014;15(6):122. - PMC - PubMed
    1. Tang J, Ip JP, Ye T, et al. Cdk5-dependent Mst3 phosphorylation and activity regulate neuronal migration through RhoA inhibition. J Neurosci. 2014;34(22):7425–7436. - PMC - PubMed

Publication types

MeSH terms

Substances